Finance

Lists
CNBX:OTCMKTS
CNBX Pharmaceuticals Inc
$0.00010
0.00%
(0.00) 1D
Nov 5, 3:47:19 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CNBX...
Mkt. cap
160.58K
Avg. vol.
9.72M
Volume
2.00
52-wk high
$0.00
52-wk low
$0.00
EPS
-$0.00
Beta
-2.14
Shares outstanding
1.61B
No. of employees
1
Mkt. cap
160.58K
Avg. vol.
9.72M
Volume
2.00
52-wk high
$0.00
52-wk low
$0.00
EPS
-$0.00
Beta
-2.14
Shares outstanding
1.61B
No. of employees
1
News stories
From web sources and news partners
About CNBX Pharmaceuticals Inc
CEO-
Employees1
Founded2004
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitecnbxpharma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Aug 2025
Nov 2025
Feb 2026
May 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
129.73K
64.00K
72.96K
162.76K
Operating expense
129.73K
64.00K
72.96K
162.76K
Total operating expenses
129.73K
64.00K
72.96K
162.76K
Operating income
-129.73K
-64.00K
-72.96K
-162.76K
Other non operating income
-
-
-
-
EBT including unusual items
-150.11K
-113.72K
-44.10K
-154.16K
EBT excluding unusual items
-150.11K
-113.72K
-44.10K
-154.16K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-150.11K
-113.72K
-44.10K
-154.16K
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
28.86K
8.60K
Interest expense
-18.28K
-49.72K
-
-
Net interest expenses
-18.28K
-49.72K
28.86K
8.60K
Depreciation and amortization charges
-
-
-
-
EBITDA
-111.65K
-
-
-
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps